Conflict of interest statement: CONFLICTS OF INTEREST The authors declare noconflicts of interest.159. Oncotarget. 2018 Feb 5;9(17):13501-13516. doi: 10.18632/oncotarget.24417.eCollection 2018 Mar 2.Increased expression of MNK1b, the spliced isoform of MNK1, predicts poorprognosis and is associated with triple-negative breast cancer.Pinto-Díez C(1), García-Recio EM(1), Pérez-Morgado MI(1), García-Hernández M(1), Sanz-Criado L(1), Sacristán S(1), Toledo-Lobo MV(2), Pérez-Mies B(3),Esteban-Rodríguez I(4), Pascual A(3), Garcia-Villanueva M(3), Martínez-JañezN(5), González VM(1), Martín ME(1).Author information: (1)Servicio de Bioquímica-Investigación, IRYCIS-Hospital Ramón y Cajal, Madrid,Spain.(2)Departamento de Biomedicina y Biotecnología, Universidad de Alcalá, Alcalá de Henares, Madrid, Spain.(3)Servicio de Anatomía Patológica, IRYCIS-Hospital Ramón y Cajal, Madrid, Spain.(4)Sevicio de Anatomía Patológica, IDYPAZ-Hospital La Paz, Madrid, Spain.(5)Servicio de Oncología, IRYCIS-Hospital Ramón y Cajal, Madrid, Spain.MAP kinase interacting kinases (MNKs) modulate the function of oncogeneeukaryotic initiation factor 4E (eIF4E) through phosphorylation, which isnecessary for oncogenic transformation. MNK1 gives rise to two mRNAs and thus twoMNK1 isoforms, named MNK1a and MNK1b. MNK1b, the splice variant of human MNK1a,is constitutively active and independent of upstream MAP kinases. In this study, we have analyzed the expression of both MNK1 isoforms in 69 breast tumor samples and its association with clinicopathologic/prognostic characteristics of breastcancer. MNK1a and MNK1b expression was significantly increased in tumors relativeto the corresponding adjacent normal tissue (p < 0.001). In addition, MNK1boverexpression was found in most of the triple-negative tumors and was associatedwith a shorter overall and disease-free survival time. Overexpression of MNK1b inMDA-MB-231 cells induced an increase in the expression of the MCL1 antiapoptotic protein and promoted proliferation, invasion and colony formation. In conclusion,a high expression level of MNK1b protein could be used as a marker of poorprognosis in breast cancer patients and it could be a therapeutic target intriple-negative tumors.DOI: 10.18632/oncotarget.24417 PMCID: PMC5862594PMID: 29568373 